Cassava Sciences Inc. (NASDAQ: SAVA) is -38.85% lower on its value in year-to-date trading and has touched a low of $1.03 and a high of $10.95 in the current 52-week trading range. The SAVA stock was last observed hovering at around $3.34 in the last trading session, with the day’s loss setting it -0.16% off its average median price target of $16.00 for the next 12 months. It is also 80.13% off the consensus price target high of $16.00 offered by 2 analysts, but current levels are 80.13% higher than the price target low of $16.00 for the same period.
Currently trading at $3.18, the stock is -3.57% and 10.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing -4.79% at the moment leaves the stock -26.18% off its SMA200. SAVA registered 135.56% gain for a year compared to 6-month loss of -60.40%. The firm has a 50-day simple moving average (SMA 50) of $3.0897 and a 200-day simple moving average (SMA200) of $5.1038.
The stock witnessed a 3.25% gain in the last 1 month and extending the period to 3 months gives it a -58.35%, and is -3.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.03% over the week and 9.53% over the month.
Distance from 52-week low is 208.74% and -70.96% from its 52-week high.
Cassava Sciences Inc. (SAVA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Cassava Sciences Inc. (SAVA) is a “Hold”. 2 analysts offering their recommendations for the stock have an average rating of 3.00, where 2 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Cassava Sciences Inc. is expected to release its quarterly report on 07/30/2020 and quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 56.70% this year.
Cassava Sciences Inc. (SAVA) Top Institutional Holders
41 institutions hold shares in Cassava Sciences Inc. (SAVA), with 2.59M shares held by insiders accounting for 10.47% while institutional investors hold 23.63% of the company’s shares. The shares outstanding are 24.48M, and float is at 22.19M with Short Float at 15.78%. Institutions hold 21.16% of the Float.
The top institutional shareholder in the company is Bleichroeder LP with over 1.74 million shares valued at $7.15 million. The investor’s holdings represent 7.02% of the SAVA Shares outstanding. As of Mar 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 0.83 million shares valued at $3.43 million to account for 3.37% of the shares outstanding. The other top investors are Renaissance Technologies, LLC which holds 0.65 million shares representing 2.64% and valued at over $2.69 million, while Sphera Funds Management Ltd holds 2.48% of the shares totaling 0.61 million with a market value of $2.53 million.
Cassava Sciences Inc. (SAVA) Insider Activity
A total of 0 insider transactions have happened at Cassava Sciences Inc. (SAVA) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by BARBIER REMI, the company’s President and CEO. SEC filings show that BARBIER REMI bought 100,000 shares of the company’s common stock on Dec 31 at a price of $5.53 per share for a total of $0.55 million. Following the purchase, the insider now owns 1.07 million shares.
Cassava Sciences Inc. disclosed in a document filed with the SEC on Dec 26 that BARBIER REMI (President and CEO) bought a total of 10,000 shares of the company’s common stock. The trade occurred on Dec 26 and was made at $4.15 per share for $41500.0. Following the transaction, the insider now directly holds 0.97 million shares of the SAVA stock.
Still, SEC filings show that on Dec 20, ROBERTSON SANFORD (Director) acquired 423,788 shares at an average price of $2.20 for $0.93 million. The insider now directly holds 662,623 shares of Cassava Sciences Inc. (SAVA).